Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Malaysia Gears Up To Launch Second VC Fund To Support Life Sciences – Biopharma Asia Conference

This article was originally published in PharmAsia News

Executive Summary

Malaysia readies to launch venture capital fund worth $100 million in the second quarter to support biopharma industry.

You may also be interested in...



Quintiles Enters Malaysia Clinical Trial Alliance For First Prime Site In Asia

SINGAPORE - Quintiles has entered an alliance with the University Malaya Medical Centre, creating its first clinical trial Prime Site in Asia, which is focused on accelerating drug development

Asia Pacific Key To Speeding Up Drug Development, Says Quintiles VP Anand Tharmaratnam: An Interview With PharmAsia News (Part 2 of 2)

Helping facilitate the globalization of clinical trials is one of Asia's main contributions in advancing the pharmaceutical industry, says Quintiles Asia Pacific Head of Clinical Development Anand Tharmaratnam, who discussed innovation in the region with PharmAsia News' Australia Bureau. While the shift to outsourcing to Asia may have begun as a cost play, it is not necessarily cheaper on every front now; in fact, some things are more expensive in Asia, such as quality control and shifting blood samples. But outsourcing to Asia is quickly becoming a strategic imperative that builds upon the region's experience and expertise. In part one, Tharmartnam discusses the changing role for contract research organizations in the region, and in part two, he drills down to discuss differences among Asia Pacific countries in terms of drug development.

Sanofi, Merck Among Firms Collaborating With Asian Governments For Drug Development – World Vaccine Congress

A Thai-French joint venture will export Japanese encephalitis vaccines to 15 Asian countries starting in 2013.

Topics

Related Companies

UsernamePublicRestriction

Register

PS140995

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel